Article
The paradigm of mutant p53-expressing cancer stem cells and drug resistance.
Carcinogenesis - 1 Jun 2014
Shetzer Yoav, Solomon Hilla, Koifman Gabriela, Molchadsky Alina, Horesh Stav, Rotter Varda
Abstract excerpt
It is well accepted that expression of mutant p53 involves the gain of oncogenic-specific activities accentuating the malignant phenotype. Depending on the specific cancer type, mutant p53 can contribute to either the early or the late events of the multiphase process underlying the transformation of a normal cell into a cancerous one. This multifactorial system is evident in ~50% of human cancers. Mutant p53 was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.